Company Filing History:
Years Active: 2001-2004
Title: Ulf Sjöbring: Innovator in Protein Research
Introduction
Ulf Sjöbring is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of protein research, particularly in the development of innovative solutions for immunoglobulin binding and bacterial infection treatment. With a total of 2 patents, his work has had a meaningful impact on both scientific research and pharmaceutical applications.
Latest Patents
Ulf Sjöbring's latest patents include groundbreaking inventions such as "Protein L and hybrid proteins thereof." This invention relates to sequences of protein L that bind to light chains of immunoglobulins. It also encompasses hybrid proteins capable of binding to both light and heavy chains of immunoglobulin G, specifically protein LG. Additionally, the patent covers DNA sequences coding for these proteins, vectors containing such DNA sequences, and transformed host cells. The methods for producing these proteins, along with reagent appliances for the separation and identification of immunoglobulins, are also included. Furthermore, his patent on "Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections" highlights the potential of kinin antagonists, particularly bradykinin antagonists, in treating infections caused by various bacteria, including Streptococcus, Escherichia, Salmonella, Staphylococcus, Klebsiella, Moracella, Haemophilus, and Yersinia.
Career Highlights
Throughout his career, Ulf has worked with several prominent companies, including Affitech AS and Actinova Limited. His experience in these organizations has allowed him to refine his expertise in protein research and development.
Collaborations
Ulf has collaborated with notable colleagues such as Lars Björck and Abdelhakim Ben Nasr. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ulf Sjöbring's innovative work in protein research and his contributions to the field through his patents demonstrate his commitment to advancing scientific knowledge and improving healthcare solutions. His inventions continue to influence the landscape of immunology and pharmaceutical development.